Close Menu

NEW YORK (360Dx) – BD announced today that the US Food and Drug Administration has cleared the BD Phoenix CPO test, which could help hospitals contain the spread of antimicrobial resistance by shortening the time to detect carbapenemase-producing organisms.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.